PNGAF OTC
The Precision Peptide Company Inc
1W: -11.8%
1M: -4.9%
3M: -23.7%
YTD: +37.1%
1Y: +15.8%
3Y: +182.4%
$0.28
-0.02 (-7.50%)
Weekly Expected Move ±8.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-429.9% ▼
Capital Expenditures
$6
+0.0% ▲
4Y CAGR: -90.2%
Free Cash Flow
-$2M
-429.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$819K
+826.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$173K | -$1M | -$2M | -$1M | -$5M |
| Depreciation & Amort. | $909 | $44K | $7K | $4K | $91K |
| Stock-Based Comp. | $0 | $76K | $347K | $109K | $0 |
| Change in Working Capital | -$357K | $263K | $240K | $369K | -$144K |
| Other Non-Cash Items | $92K | $33K | $412K | $110K | $2M |
| Operating Cash Flow | -$530K | -$719K | -$981K | -$439K | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$61K | -$7K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$270K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$63K | -$7K | $0 | $0 | $0 |
| Investing Cash Flow | -$61K | -$7K | $0 | $0 | -$270K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$46K | $0 | $18K | -$18K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1M | $30K | $191K | $0 | $0 |
| Financing Cash Flow | $1M | -$1K | $956K | $528K | $3M |
| Net Change in Cash | $808K | -$732K | -$24K | $88K | $819K |
| Cash End of Period | $808K | $76K | $52K | $140K | $960K |
| Free Cash Flow | -$591K | -$726K | -$981K | -$439K | -$2M |